Stone Toro Investment Advisers’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Stone Toro Investment Advisers’s Portfolio ASTX Stock Details ASTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-10,000	Closed	-$85K	–	192
2013 Q3	$85K	Buy	+10,000	New	+$63.3K	0.06%	153

Stone Toro Investment Advisers's ASTX Position: Q4 2013 in Review

Stone Toro Investment Advisers sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 10,000 shares — an estimated $85K sold.

Stone Toro Investment Advisers first reported a position in ASTX in Q3 2013 and held it in 1 quarter. The position peaked at $85K in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

Stone Toro Investment Advisers reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
Stone Toro Investment Advisers sold 10,000 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $85K.
Stone Toro Investment Advisers first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q3 2013 and held it in 1 quarter.
Stone Toro Investment Advisers's ASTEX PHARMACEUTICALS, INC COM position peaked at $85K in Q3 2013.
0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Stone Toro Investment Advisers's 13F filing for Q4 2013, filed 28 Jan 2014.